A newly released study by the University of Florida Health has cast serious doubt on the effectiveness of Body Mass Index (BMI) as a predictor of long-term health, particularly in assessing the risk of death. Long used as a standard tool to classify individuals as underweight, healthy, overweight, or obese, BMI has been widely adopted in clinical and public health settings. However, the study, published on June 24 in the Annals of Family Medicine, finds that this standard metric fails to provide an accurate picture of an individual’s future health prospects, particularly in terms of mortality risk. The researchers argue that the measure is fundamentally flawed and should no longer be relied upon as the default method for assessing obesity and its associated health risks.
The study compared BMI with a more direct and biologically relevant technique: bioelectrical impedance analysis (BIA). Unlike BMI, which is based on a simple calculation of weight divided by height squared, BIA measures the body’s resistance to a low electrical current to estimate body fat levels. This method provides a more specific insight into body composition, distinguishing between fat and lean tissue. Over a 15-year tracking period, individuals with high body fat as measured by BIA were shown to have a 78% increased risk of death from any cause compared to those with normal fat levels. More strikingly, they were approximately 3.5 times more likely to die from cardiovascular disease. These findings suggest that BIA offers a much more reliable indication of health outcomes than BMI.
In sharp contrast, BMI proved ineffective in predicting mortality. The data revealed no statistically significant association between BMI and the risk of death from any cause, including heart disease. This lack of correlation persisted even after researchers adjusted for potential confounding factors, including age, race, and income. The study’s authors concluded that BMI’s inability to account for the distribution and composition of body weight — particularly the distinction between muscle and fat — renders it obsolete as a tool for predicting health risks. Its use as a surrogate for body fat, they argue, has led to the widespread misclassification of individuals, sometimes with significant consequences for patient care and policy.
The research was spearheaded by a team in the Department of Community Health and Family Medicine at the University of Florida’s College of Medicine. Lead author Professor Arch Mainous described the findings as a definitive comparison between two competing methods for assessing body fat. Drawing a parallel with product testing, he said, “This is the ultimate Coke versus Pepsi test. And BMI failed.” This memorable analogy underscores the dramatic underperformance of BMI in a head-to-head comparison. The study’s findings suggest that continued reliance on BMI may not only be unhelpful but could actively obscure underlying health issues, delaying more accurate diagnosis and intervention.
The data underpinning the study were drawn from the National Health and Nutrition Examination Survey (NHANES). This long-standing and nationally representative dataset links health information with mortality outcomes from the National Death Index. The researchers analysed the health data of 4,252 individuals, a cohort selected to reflect the demographic makeup of the United States population. This breadth of data lends considerable weight to the findings and increases their relevance to both clinicians and public health policymakers. By using a dataset that spans more than a decade and includes diverse participants, the study offers strong evidence that its conclusions are both valid and generalisable.
One of the study’s senior authors, Dr Frank Orlando, who serves as medical director of UF Health Family Medicine – Springhill, offered a clinical perspective on the implications of the findings. As a family physician, he noted the routine use of BMI as a kind of surrogate vital sign. This quick, easily calculated figure is supposedly a reliable indicator of a patient’s health. However, Dr Orlando criticised this approach, noting that BMI lacks the specificity and accuracy of actual vital signs. “We use BMI to sort of screen for a person having an issue with their body composition, but it’s not accurate for everyone like vital signs are,” he explained. For many patients, especially those with atypical body types or varying muscle mass, BMI may mislead rather than inform.
Ultimately, the study’s conclusions call for a critical reassessment of how health professionals and institutions evaluate body composition and obesity-related risk. BMI, despite its simplicity and ubiquity, appears no longer fit for purpose in a modern healthcare environment that increasingly values precision, equity, and individualised care. By contrast, bioelectrical impedance analysis offers a more nuanced and biologically valid assessment method, and one that is becoming increasingly accessible in clinical settings. As our understanding of obesity and its consequences evolves, so too must the tools we use to assess and manage it. This study adds to the growing consensus that a shift away from BMI is not only necessary but long overdue.
More information: Arch Mainous et al, Body Mass Index vs Body Fat Percentage as a Predictor of Mortality in Adults Aged 20-49 Years, The Annals of Family Medicine. DOI: 10.1370/afm.240330
Journal information: The Annals of Family Medicine Provided by University of Florida
